2020
Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis
Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM, Porras D, Morgan GJ, Bauser Heaton H, Martin MH, Keeshan B, Asnes JD, Kenny D, Ringewald JM, Zablah JE, Ivy M, Morray BH, Torres AJ, Berman DP, Gillespie MJ, Chaszczewski K, Zampi JD, Walsh KP, Julien P, Goldstein BH, Sathanandam SK, Karsenty C, Balzer DT, McElhinney DB. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. Journal Of The American College Of Cardiology 2020, 76: 2847-2858. PMID: 33303074, DOI: 10.1016/j.jacc.2020.10.041.Peer-Reviewed Original ResearchConceptsTranscatheter pulmonary valve replacementPulmonary valve replacementSAPIEN XTValve replacementS3 valveMost patientsShort-term outcome dataGreater pulmonary regurgitationMaximum Doppler gradientOutflow tract anatomyTricuspid valve injurySAPIEN 3 valveSerious adverse eventsBalloon-expandable valveShort-term outcomesSurgical valve replacementValve complicationsMulticenter registryUrgent surgeryAdverse eventsDoppler gradientPulmonary regurgitationSAPIEN prosthesisTotal patientsValve injury
2018
Intentional Fracture of Bioprosthetic Valve Frames in Patients Undergoing Valve-in-Valve Transcatheter Pulmonary Valve Replacement
Shahanavaz S, Asnes JD, Grohmann J, Qureshi AM, Rome JJ, Tanase D, Crystal MA, Latson LA, Morray BH, Hellenbrand W, Balzer DT, Gewillig M, Love JC, Berdjis F, Gillespie MJ, McElhinney DB. Intentional Fracture of Bioprosthetic Valve Frames in Patients Undergoing Valve-in-Valve Transcatheter Pulmonary Valve Replacement. Circulation Cardiovascular Interventions 2018, 11: e006453. PMID: 30354783, DOI: 10.1161/circinterventions.118.006453.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationChildFeasibility StudiesFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHemodynamicsHumansMaleMiddle AgedPreliminary DataProsthesis DesignProsthesis FailurePulmonary ValveRecovery of FunctionRetrospective StudiesTime FactorsTreatment OutcomeYoung AdultConceptsTranscatheter pulmonary valve replacementPulmonary valve replacementBioprosthetic valvesValve replacementPercutaneous transcatheter pulmonary valve replacementRight ventricular outflow tract gradientVentricular outflow tract gradientDysfunctional bioprosthetic valvePulmonary valve orificeOutflow tract gradientPatient-prosthesis mismatchIntentional fractureTrue inner diameterMedian 40Tract gradientMelody valveSAPIEN valveAdverse eventsHemodynamic outcomesValve therapyFracture groupPeak gradientControl cohortPulmonary positionBetter hemodynamics
2017
Ventricular arrhythmias immediately following transcatheter pulmonary valve implantation: A cause for concern?
Simmons MA, Elder RW, Shabanova V, Hellenbrand W, Asnes J. Ventricular arrhythmias immediately following transcatheter pulmonary valve implantation: A cause for concern? Catheterization And Cardiovascular Interventions 2017, 91: 920-926. PMID: 29280541, DOI: 10.1002/ccd.27454.Peer-Reviewed Original ResearchConceptsTranscatheter pulmonary valve implantationRight ventricular outflow tractNative outflow tractsSignificant ventricular arrhythmiasPulmonary valve implantationVentricular arrhythmiasOutflow tractValve implantationAnti-arrhythmic medicationsBeta-blocker therapySingle-center studyVentricular outflow tractLong-term therapySudden cardiac deathCare of patientsChange of doseHemodynamic instabilityHemodynamic compromiseCardiac deathMedian ageMedical therapyPediatric patientsSignificant arrhythmiasCenter studyTerm therapyTranscatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study
Cabalka AK, Asnes JD, Balzer DT, Cheatham JP, Gillespie MJ, Jones TK, Justino H, Kim DW, Lung TH, Turner DR, McElhinney DB. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study. Journal Of Thoracic And Cardiovascular Surgery 2017, 155: 1712-1724.e1. PMID: 29395214, DOI: 10.1016/j.jtcvs.2017.10.143.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationChildChild, PreschoolFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedProsthesis DesignProsthesis FailurePulmonary ValvePulmonary Valve InsufficiencyPulmonary Valve StenosisRecovery of FunctionRetrospective StudiesTime FactorsTreatment OutcomeUnited StatesYoung AdultConceptsPulmonary valve replacementTPV replacementPulmonary regurgitationBioprosthetic valvesValve replacementMulticenter studyRight ventricular outflow tract gradientPostoperative congenital heart diseaseTranscatheter pulmonary valve replacementVentricular outflow tract gradientSurgical pulmonary valve replacementMean RVOT gradientMedian patient ageOutflow tract gradientSevere pulmonary regurgitationExcellent early resultsSurgical bioprosthetic valvesTetralogy of FallotCongenital heart diseaseTime-related fashionRVOT gradientTract gradientUnderlying diagnosisHospital dischargePatient ageComparison of valvar and right ventricular function following transcatheter and surgical pulmonary valve replacement
Li WF, Pollard H, Karimi M, Asnes JD, Hellenbrand WE, Shabanova V, Weismann CG. Comparison of valvar and right ventricular function following transcatheter and surgical pulmonary valve replacement. Congenital Heart Disease 2017, 13: 140-146. PMID: 29148206, PMCID: PMC5796854, DOI: 10.1111/chd.12544.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBioprosthesisCardiac CatheterizationChildChild, PreschoolEchocardiographyFemaleFollow-Up StudiesHeart Valve Prosthesis ImplantationHeart VentriclesHumansMaleMiddle AgedPulmonary ValvePulmonary Valve InsufficiencyRetrospective StudiesTime FactorsTreatment OutcomeVentricular Function, RightVentricular RemodelingYoung AdultConceptsRight ventricular outflow tract obstructionPulmonary valve replacementSurgical pulmonary valve replacementRight ventricular functionPulmonic insufficiencyVentricular functionTC groupRV functionSurgical groupValve replacementRV sizeVentricular outflow tract obstructionYale-New Haven HospitalOutflow tract obstructionTract obstructionPatient ageRetrospective reviewSurgical valvesPostoperative declinePulmonary valveHigh riskValve functionPatientsFirst choiceTime pointsOutcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly
Taggart NW, Cabalka AK, Eicken A, Aboulhosn JA, Thomson JDR, Whisenant B, Bocks ML, Schubert S, Jones TK, Asnes JD, Fagan TE, Meadows J, Hoyer M, Martin MH, Ing FF, Turner DR, Latib A, Tzifa A, Windecker S, Goldstein BH, Delaney JW, Kuo JA, Foerster S, Gillespie M, Butera G, Shahanavaz S, Horlick E, Boudjemline Y, Dvir D, McElhinney DB, Registry V. Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. The American Journal Of Cardiology 2017, 121: 262-268. PMID: 29153244, DOI: 10.1016/j.amjcard.2017.10.017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationEbstein AnomalyEndocarditisFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedPostoperative ComplicationsProsthesis FailureRegistriesReoperationThrombosisTreatment OutcomeTricuspid ValveTricuspid Valve InsufficiencyYoung AdultConceptsEbstein's anomalyValve dysfunctionValve implantationTricuspid valveAcute valve thrombosisMedium-term durabilityPatient underwent reinterventionPatient-prosthesis mismatchSevere tricuspid regurgitationTranscatheter Tricuspid ValveNYHA statusProcedural mortalityTranscatheter tricuspidUnderwent reinterventionMelody valveValve thrombosisMost patientsTricuspid regurgitationCommon indicationAcute resultsSurgical bioprosthesesInternational registryInvasive alternativePatientsTVIV
2016
Transcatheter valve implantation for right atrium‐to‐right ventricle conduit obstruction or regurgitation after modified Björk–fontan procedure
Shah AH, Horlick EM, Eicken A, Asnes JD, Bocks ML, Boudjemline Y, Cabalka AK, Fagan TE, Schubert S, Mahadevan VS, Dvir D, Osten M, McElhinney DB. Transcatheter valve implantation for right atrium‐to‐right ventricle conduit obstruction or regurgitation after modified Björk–fontan procedure. Catheterization And Cardiovascular Interventions 2016, 89: 298-305. PMID: 27465501, DOI: 10.1002/ccd.26648.Peer-Reviewed Original ResearchMeSH KeywordsAdultBioprosthesisBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationCanadaCardiac CatheterizationEuropeFemaleFontan ProcedureGraft Occlusion, VascularHeart Defects, CongenitalHeart Valve DiseasesHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHemodynamicsHumansMaleMiddle AgedNorth AmericaProsthesis DesignProsthesis FailureRecovery of FunctionRegistriesRetrospective StudiesStentsTime FactorsTreatment OutcomeConceptsRight ventricleBjörk modificationFontan procedureValve implantationExtra-anatomic graftRetrospective multicenter registrySapien valve implantationLow procedural riskTranscatheter valve implantationRight atrial appendageCardiovascular causesPercutaneous transcatheterRA-RVUncomplicated implantationMulticenter registrySAPIEN 3Clinical improvementValve dysfunctionConduit dysfunctionFontan circulationPulmonary circulationAtrial appendageFontan pathwayTranscatheter implantationProcedural riskTranscatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves
McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP, Momenah TS, Kim DW, Schranz D, Meadows J, Thomson JD, Goldstein BH, Crittendon I, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK, Shahanavaz S, Moretti C, Hainstock MR, Kenny DP, Berger F, Rihal CS, Dvir D. Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves. Circulation 2016, 133: 1582-1593. PMID: 26994123, DOI: 10.1161/circulationaha.115.019353.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBioprosthesisCardiac CatheterizationChildChild, PreschoolFemaleFollow-Up StudiesHeart Valve Prosthesis ImplantationHumansInternationalityLength of StayMaleMiddle AgedProsthesis FailureRegistriesTreatment OutcomeTricuspid Valve InsufficiencyYoung AdultConceptsNew York Heart Association class IIIClass IIITV dysfunctionValve implantationNew York Heart Association class IValve sizePulmonary valve prosthesisTricuspid regurgitation gradePatient-related factorsSurgical bioprosthetic valvesTranscatheter Tricuspid ValveTV reinterventionsMulticenter registrySAPIEN valveMedian ageRegurgitation gradeSerious complicationsClinical statusTricuspid valveLabel useTranscatheter prosthesesBioprosthetic valvesValve prosthesisPatientsValve bioprostheses
2008
Causes of Recurrent Focal Neurologic Events After Transcatheter Closure of Patent Foramen Ovale With the CardioSEAL Septal Occluder
Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA. Causes of Recurrent Focal Neurologic Events After Transcatheter Closure of Patent Foramen Ovale With the CardioSEAL Septal Occluder. The American Journal Of Cardiology 2008, 101: 1487-1492. PMID: 18471463, DOI: 10.1016/j.amjcard.2008.01.028.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCardiac CatheterizationCatheterizationConfidence IntervalsEmbolism, ParadoxicalEquipment DesignFemaleFollow-Up StudiesForamen Ovale, PatentHumansIncidenceIschemic Attack, TransientMagnetic Resonance ImagingMaleMiddle AgedPrognosisProportional Hazards ModelsRecurrenceRetrospective StudiesRisk FactorsStrokeTime FactorsTomography, X-Ray ComputedTreatment OutcomeUnited StatesConceptsStroke/transient ischemic attackTransient ischemic attackFocal neurologic eventsPFO closureRecurrent strokeNeurologic eventsMedical managementRecurrent stroke/transient ischemic attackEvent ratesOngoing randomized trialsPatent foramen ovaleTranscatheter PFO closureTranscatheter patent foramenCardioSEAL Septal OccluderEmbolic episodesIschemic attackPFO occlusionParadoxical emboliImmediate morbidityConsecutive patientsPatent foramenRandomized trialsTranscatheter closureForamen ovaleRecurrence rate